Long X, Li F, Tang S, Liu J, Fu Y, & Feng Y. (2024). scRNA-Seq and Bulk-Seq Analysis Identifies S100A9 Plasma Cells as a Potentially Effective Immunotherapeutic Agent for Multiple Myeloma. Dove Medical Press.
Chicago Style (17th ed.) CitationLong X, Li F, Tang S, Liu J, Fu Y, and Feng Y. ScRNA-Seq and Bulk-Seq Analysis Identifies S100A9 Plasma Cells as a Potentially Effective Immunotherapeutic Agent for Multiple Myeloma. Dove Medical Press, 2024.
MLA (9th ed.) CitationLong X, et al. ScRNA-Seq and Bulk-Seq Analysis Identifies S100A9 Plasma Cells as a Potentially Effective Immunotherapeutic Agent for Multiple Myeloma. Dove Medical Press, 2024.
Warning: These citations may not always be 100% accurate.